Premier Inc., a huge U.S. hospital purchasing group, inks new deals for drug-coated stents with...

|By:, SA News Editor

Premier Inc., a huge U.S. hospital purchasing group, inks new deals for drug-coated stents with Abbott (ABT -0.5%) and J&J (JNJ -1.5%). Johnson, the coated stent pioneer, finds itself playing second fiddle to ABT's Xience, which quickly vaulted to #1 after coming on the market last summer.